SG11201509307VA - Crystalline forms of zinc trisodium pentetic acid - Google Patents
Crystalline forms of zinc trisodium pentetic acidInfo
- Publication number
- SG11201509307VA SG11201509307VA SG11201509307VA SG11201509307VA SG11201509307VA SG 11201509307V A SG11201509307V A SG 11201509307VA SG 11201509307V A SG11201509307V A SG 11201509307VA SG 11201509307V A SG11201509307V A SG 11201509307VA SG 11201509307V A SG11201509307V A SG 11201509307VA
- Authority
- SG
- Singapore
- Prior art keywords
- crystalline forms
- pentetic acid
- zinc trisodium
- trisodium
- zinc
- Prior art date
Links
- QPCDCPDFJACHGM-UHFFFAOYSA-N N,N-bis{2-[bis(carboxymethyl)amino]ethyl}glycine Chemical compound OC(=O)CN(CC(O)=O)CCN(CC(=O)O)CCN(CC(O)=O)CC(O)=O QPCDCPDFJACHGM-UHFFFAOYSA-N 0.000 title 1
- IJLZPISNKPJMNS-UHFFFAOYSA-N [Zn].[Na].[Na].[Na] Chemical compound [Zn].[Na].[Na].[Na] IJLZPISNKPJMNS-UHFFFAOYSA-N 0.000 title 1
- 229960003330 pentetic acid Drugs 0.000 title 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/06—Zinc compounds
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
- C07F3/00—Compounds containing elements of Groups 2 or 12 of the Periodic Table
- C07F3/003—Compounds containing elements of Groups 2 or 12 of the Periodic Table without C-Metal linkages
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K33/00—Medicinal preparations containing inorganic active ingredients
- A61K33/24—Heavy metals; Compounds thereof
- A61K33/30—Zinc; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K49/00—Preparations for testing in vivo
- A61K49/06—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations
- A61K49/20—Nuclear magnetic resonance [NMR] contrast preparations; Magnetic resonance imaging [MRI] contrast preparations containing free radicals, e.g. trityl radical for overhauser
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Epidemiology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Radiology & Medical Imaging (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Inorganic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Inorganic Compounds Of Heavy Metals (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201361826507P | 2013-05-23 | 2013-05-23 | |
| EP13168851.7A EP2805957A1 (en) | 2013-05-23 | 2013-05-23 | Crystalline Forms of Trisodium zink diethylene triamine pentaacetic acid |
| PCT/EP2014/060600 WO2014187930A1 (en) | 2013-05-23 | 2014-05-23 | Crystalline forms of zinc trisodium pentetic acid |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| SG11201509307VA true SG11201509307VA (en) | 2015-12-30 |
Family
ID=48446196
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| SG11201509307VA SG11201509307VA (en) | 2013-05-23 | 2014-05-23 | Crystalline forms of zinc trisodium pentetic acid |
Country Status (15)
| Country | Link |
|---|---|
| US (1) | US9447120B2 (en) |
| EP (2) | EP2805957A1 (en) |
| JP (1) | JP2016522828A (en) |
| CY (1) | CY1119385T1 (en) |
| DK (1) | DK2999706T3 (en) |
| ES (1) | ES2639229T3 (en) |
| HR (1) | HRP20171308T1 (en) |
| HU (1) | HUE034139T2 (en) |
| LT (1) | LT2999706T (en) |
| PL (1) | PL2999706T3 (en) |
| PT (1) | PT2999706T (en) |
| RS (1) | RS56325B1 (en) |
| SG (1) | SG11201509307VA (en) |
| SI (1) | SI2999706T1 (en) |
| WO (1) | WO2014187930A1 (en) |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3062719A (en) | 1959-10-19 | 1962-11-06 | Geigy Chem Corp | Trisodium calcium diethylenetriaminepentaacetic acid, compositions containing the same, and the use thereof |
| DE1223396B (en) | 1964-01-14 | 1966-08-25 | Geigy Ag J R | Process for the preparation of trisodium salts of the zinc complexes of diaethylenetriamine-N, N. N ', N ", N" -pentaacetic acid and of triaethylenetetramine-N, N, N', N ", N" ', N "' - hexaacetic acid |
| US3501577A (en) * | 1967-11-21 | 1970-03-17 | Cooper Lab | Method of treating hypertension with alkali metal salts of zinc diethylenetriaminepentaacetate |
| EP1413575B1 (en) | 1999-08-03 | 2006-10-11 | Ortho-McNeil Pharmaceutical, Inc. | Process for preparing derivatives of ¬(1,5-diaryl)pyrazol-3-yl|propanoic acid |
| US8074906B2 (en) | 2005-07-07 | 2011-12-13 | Nanotherapeutics, Inc. | Process for milling and preparing powders and compositions produced thereby |
| AU2007259408B2 (en) | 2006-02-17 | 2010-03-04 | Sri International | Oral DTPA for radionuclide chelation |
-
2013
- 2013-05-23 EP EP13168851.7A patent/EP2805957A1/en not_active Withdrawn
-
2014
- 2014-05-23 WO PCT/EP2014/060600 patent/WO2014187930A1/en active Application Filing
- 2014-05-23 PT PT147277750T patent/PT2999706T/en unknown
- 2014-05-23 SG SG11201509307VA patent/SG11201509307VA/en unknown
- 2014-05-23 JP JP2016514425A patent/JP2016522828A/en active Pending
- 2014-05-23 ES ES14727775.0T patent/ES2639229T3/en active Active
- 2014-05-23 RS RS20170863A patent/RS56325B1/en unknown
- 2014-05-23 HU HUE14727775A patent/HUE034139T2/en unknown
- 2014-05-23 LT LTEP14727775.0T patent/LT2999706T/en unknown
- 2014-05-23 SI SI201430350T patent/SI2999706T1/en unknown
- 2014-05-23 DK DK14727775.0T patent/DK2999706T3/en active
- 2014-05-23 EP EP14727775.0A patent/EP2999706B1/en active Active
- 2014-05-23 PL PL14727775T patent/PL2999706T3/en unknown
- 2014-05-23 US US14/893,385 patent/US9447120B2/en active Active
-
2017
- 2017-08-28 CY CY20171100903T patent/CY1119385T1/en unknown
- 2017-08-30 HR HRP20171308TT patent/HRP20171308T1/en unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CY1119385T1 (en) | 2018-02-14 |
| WO2014187930A1 (en) | 2014-11-27 |
| RS56325B1 (en) | 2017-12-29 |
| LT2999706T (en) | 2017-09-25 |
| EP2999706B1 (en) | 2017-07-19 |
| EP2805957A1 (en) | 2014-11-26 |
| EP2999706A1 (en) | 2016-03-30 |
| PT2999706T (en) | 2017-09-05 |
| ES2639229T3 (en) | 2017-10-25 |
| US20160130283A1 (en) | 2016-05-12 |
| PL2999706T3 (en) | 2017-12-29 |
| HRP20171308T1 (en) | 2017-11-17 |
| US9447120B2 (en) | 2016-09-20 |
| JP2016522828A (en) | 2016-08-04 |
| SI2999706T1 (en) | 2017-11-30 |
| HUE034139T2 (en) | 2018-01-29 |
| DK2999706T3 (en) | 2017-09-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| HK1224226A1 (en) | Nicotine salt with m eta-salicylic acid | |
| HUE039718T2 (en) | Crystalline form i of ibrutinib | |
| EP2876724A4 (en) | Method of manufacturing secondary battery | |
| HUE053629T2 (en) | Method for smelterless recycling of lead acid batteries | |
| SI3083554T1 (en) | Dimethylbenzoic acid compounds | |
| RU2016118399A3 (en) | 4-aminomethylbenzoic acid derivative | |
| HK1217331A1 (en) | Crystalline forms of [1-cyano-5-(4-chlorophenoxy)-4-hydroxy- isoquinoline-3-carbonyl]-amino-acetic acid [1--5-(4-)-4---3-]-- | |
| HUE048326T2 (en) | Beta-hydroxy-beta-methylbutyric acid purification method | |
| HK1222385A1 (en) | Dicarboxylic acid compound | |
| HUE043922T2 (en) | Novel hydroxamic acid derivative or salt thereof | |
| HK1214248A1 (en) | Heterocyclic acetic acid amide compound | |
| HK1212978A1 (en) | Novel derivatives of sinapinic acid | |
| HK1220187A1 (en) | A crystalline form of an anxiolytic compound | |
| PL2980079T3 (en) | Method of manufacturing pyridazinone compound | |
| SG11201509307VA (en) | Crystalline forms of zinc trisodium pentetic acid | |
| HK1214596A1 (en) | Crystalline form of a substituted thiazolylacetic acid triethylamine salt | |
| EP2970188A4 (en) | Novel crystalline forms | |
| GB201322785D0 (en) | Manufacture of lactic acid |